BioInformant

Your Global Leader in Stem Cell Market Research

At the American Academy of Stem Cell Physicians Live Congress 2019, FDA Safety Panel Says No to the Bad Actors

By Leave a Comment

*Photo: Dr. Warren Bleiweiss showing off new AASCP Board Certification.

The American Academy of Stem Cell Physicians hosted a panel on Nov. 2 to discuss safety standards for Physicians who practice stem cell medicine.

MIAMI, November 6, 2019 — The American Academy of Stem Cell Physicians (AASCP) was joined by the the alliance leader Janet Marchibroda in hosting a safety standards panel on November second at the AASCP Live Congress 2019. The panel, which was moderated by Janet Marchibroda, the president of The Alliance for cell therapy now, also attending via Skype Dr Peter Marks director of the Center for Biologics and Evaluation and Research, was well-received by physicians from around the world. [Read more…]

Stemmatters, a Portuguese Integrated Therapeutics Developer and Cell Therapy CDMO

By Leave a Comment

Stemmatters is a Portuguese contract development and manufacturing (CDMO) organisation based in Barco, Guimarães. Originally a spin-off from University of Minho, it offers contract development and manufacturing services for cell-based advanced therapies, exosomes, blood-derived biologics, tissue products, biomaterials, and combination devices.

In the interview below, we explore Stemmatters history, services, manufacturing facilities, and future goals. Enjoy! [Read more…]

Synthego Launches High-Throughput Induced Pluripotent Stem Cell Genome Engineering

By Leave a Comment

National Institutes of Health awards contract for CRISPR-based disease modeling in iPS cell lines associated with Alzheimer’s, Stem cell pioneer Bill Skarnes joins advisory board

REDWOOD CITY, Calif., Oct. 22, 2019 — Synthego, the leading genome engineering company, announced the launch of genome engineering for induced pluripotent stem (iPS) cells. The new offering expands Synthego’s automated cell editing to achieve unprecedented editing efficiency of iPS cells at an industrial scale. [Read more…]

Where Do Stem Cells Come From? | Basics Of Stem Cell Therapy

By Leave a Comment

Where do stem cells come from? Learn the basics of master cells to better understand their therapeutic potential.

In this article:

  1. An Introduction to Human Stem Cells
  2. Types of Stem Cells
  3. Where Do Stem Cells Come From?
  4. The Donation Process
  5. What Can Stem Cells Treat?
  6. Stem Cells for Testing New Drugs
  7. The Benefits of Stem Cell Transplant
  8. The Survival Rate of Stem Cell Therapy

[Read more…]

100+ Current and Future Uses of Umbilical Cord Stem Cells

By Leave a Comment

Umbilical cord stem cells are present within the cord that connects a newborn to its mother and uses of these birth cells include treating cancers, diseases, injuries, and more. Umbilical cord blood contains hematopoietic stem cells (HSCs), which are multipotent stem cells that can give rise to other blood and immune system cells.

Stem cells can also be collected from a newborn’s:

  • Umbilical cord tissue (Wharton’s jelly)
  • Placenta
  • Amnion

Most commonly, hematopoietic stem cells (HSCs) from cord blood are used to treat blood cancers, such as leukemia. When compared to hematopoietic stem cells from genetically matched bone marrow donor, cord blood HSCs may provide some medical advantages, including fewer immune system complications, such as graft-versus-host disease (GvHD).

In recent years, regenerative medicine has continued to increase the list of medical uses for stem cells from umbilical cord. Find out more about current and future uses of umbilical cord stem cells below.

In this article:

  1. Current Uses of Stem Cells
  2. Potential Uses for Stem Cells

[Read more…]

BioInformant's World-Class Clients